XYL Stock Analysis: Xylem | NYSE

Water Pumps, Wastewater Treatment, Smart Meters, Filtration

Total Rating 51

Safety 84

Buy Signal -0.22

Specialty Industrial Machinery
Industry Rotation: +6.8

Market Cap: 27.9B
Avg Turnover: 225M

Risk 3d forecast

Volatility25.4%

VaR 5^th Pctl4.26%

VaR vs Median1.66%

Reward TTM

Sharpe Ratio-0.70

Rel. Str. IBD16.1

Rel. Str. Peer Group23.2

Character TTM

Beta0.724

Beta Downside0.893

Hurst Exponent0.408

Drawdowns 3y

Max DD30.04%

CAGR/Max DD0.26

CAGR/Mean DD0.78

EPS (Earnings per Share)

EPS CAGR: 16.16%
EPS Trend: 99.7%

Last SUE: 2.49
Qual. Beats: 1

Revenue

Rev. CAGR: 9.52%
Rev. Trend: 89.6%

Last SUE: -0.10
Qual. Beats: 0

Warnings

Below Avwap Earnings

Below Sma 200d

Tailwinds

No distinct edge detected

Seasonality 11.6 years of data

Jan -1.3% 21

Feb -0.4% 5

Mar +0.3% 5

Apr -0.1% 10

May -0.3% 5

Jun +0.7% 8

Jul +0.9% 20

Aug +2.0% 14

Sep -0.5% 14

Oct -0.5% 0

Nov +3.0% 26

Dec -4.4% 29

How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.

Description: XYL Xylem

Xylem Inc. (NYSE: XYL) is a U.S.-based industrial company that designs, manufactures, and services engineered water-related products and solutions for utility, industrial, and residential/commercial customers worldwide. Incorporated in 2011 (originally as ITT WCO, Inc.) and headquartered in Washington, D.C., the company completed its IPO in October 2011 and is classified within the Industrials sector (sub-industry: Industrial Machinery & Supplies & Components).

The business is organized into four segments-Water Infrastructure, Applied Water, Measurement and Control Solutions, and Water Solutions and Services. Its offering spans pumps and controls, filtration, disinfection and biological treatment equipment, heat exchangers, valves, and dispensing systems for water handling, as well as smart meters, network communications, sensors, data analytics, and cloud-based remote monitoring and asset management software.

Xylem markets these products under a broad brand portfolio, including Flygt, Wedeco, Wallace & Tiernan, Leopold, Goulds Water Technology, Bell & Gossett, Lowara, Jabsco, Sensus, YSI, and Xylem Vue. It also delivers preventative maintenance, mobile field services, environmental remediation, odor and corrosion control, and rental/dewatering services under brands such as Grindex, Mar Cor, and Godwin.

Sector context: Xylem operates in the global water technology and equipment industry, where long-term demand is shaped by population growth, urbanization, climate-related water stress, and the replacement of aging municipal water and wastewater infrastructure. The company serves both regulated utility customers and private industrial users, and sits within a competitive landscape that includes other diversified water technology and metering providers serving the same infrastructure-renewal and efficiency-driven end markets.

Headlines to Watch Out For

Evoqua integration expands water treatment margins and recurring revenue
US infrastructure bill funding boosts Water Infrastructure segment orders
Smart metering adoption accelerates amid utility digitalization mandates

Piotroski VR-10 (Strict) 9.0

Net Income: 1.01b TTM > 0 and > 6% of Revenue
FCF/TA: 0.06 > 0.02 and ΔFCF/TA 0.41 > 1.0
NWC/Revenue: 18.30% < 20% (prev 23.69%; Δ -5.39% < -1%)
CFO/TA 0.08 > 3% & CFO 1.30b > Net Income 1.01b
Net Debt (1.91b) to EBITDA (1.86b): 1.03 < 3
Current Ratio: 1.61 > 1.5 & < 3
Outstanding Shares: last quarter (236.6m) vs 12m ago -2.99% < -2%
Gross Margin: 39.24% > 18% (prev 37.82%; Δ 1.42% > 0.5%)
Asset Turnover: 52.85% > 50% (prev 50.78%; Δ 2.08% > 0%)
Interest Coverage Ratio: 56.35 > 6 (EBIT TTM 1.30b / Interest Expense TTM 23.0m)

Altman Z'' 3.46

A: 0.10 (Total Current Assets 4.39b - Total Current Liabilities 2.72b) / Total Assets 17.3b
B: 0.23 (Retained Earnings 3.96b / Total Assets 17.3b)
C: 0.08 (EBIT TTM 1.30b / Avg Total Assets 17.3b)
D: 1.51 (Book Value of Equity 10.4b / Total Liabilities 6.92b)
Altman-Z'' = 3.46 = A

Beneish M -3.05

DSRI: 0.98 (Receivables 1.88b/1.84b, Revenue 9.13b/8.73b)
GMI: 0.96 (GM 37.82% / 39.24%)
AQI: 1.00 (AQ_t 0.68 / AQ_t-1 0.68)
SGI: 1.05 (Revenue 9.13b / 8.73b)
TATA: -0.02 (NI 1.01b - CFO 1.30b) / TA 17.3b)
Beneish M = -3.05 (Cap -4..+1) = AA

What is the price of XYL shares?

As of August 17, 2026, the stock is trading at USD 119.68 with a total of 841,014 shares traded. Over the past week, the price has changed by -0.53%, over one month by -4.49%, over three months by +10.94% and over the past year by -13.93%.

Current recommended Stop Loss: 115.50 (which is 3.5% or 1.3 ATR below the current price).

Is XYL a buy, sell or hold?

Xylem has received a consensus analysts rating of 4.05. Therefore, it is recommended to buy XYL.

StrongBuy: 9
Buy: 5
Hold: 8
Sell: 0
StrongSell: 0

What are the forecasts/targets for the XYL price?

Analysts Target Price	153.2	28%

Xylem (XYL) - Fundamental Data Overview as of 16 August 2026

Market Cap USD = 27.9b (27.9b USD * 1.0 USD.USD)
P/E Trailing = 28.6316
P/E Forward = 21.7865
P/S = 3.062
P/B = 2.7153
P/EG = 1.6575
Revenue TTM = 9.13b USD
EBIT TTM = 1.30b USD
EBITDA TTM = 1.86b USD
Long Term Debt = 2.40b USD (from longTermDebt, last quarter)
Short Term Debt = 660.0m USD (from shortTermDebt, last quarter)
Debt = 3.18b USD (from shortLongTermDebtTotal, last quarter) + Leases 129.0m
Net Debt = 1.91b USD (calculated: Debt 3.18b - CCE 1.28b)
Enterprise Value = 29.9b USD (27.9b + Debt 3.18b - CCE 1.28b)
Interest Coverage Ratio = 56.35 (Ebit TTM 1.30b / Interest Expense TTM 23.0m)
EV/FCF = 31.10x (Enterprise Value 29.9b / FCF TTM 960.0m)
FCF Yield = 3.22% (FCF TTM 960.0m / Enterprise Value 29.9b)
FCF Margin = 10.52% (FCF TTM 960.0m / Revenue TTM 9.13b)
Net Margin = 11.07% (Net Income TTM 1.01b / Revenue TTM 9.13b)
Gross Margin = 39.24% ((Revenue TTM 9.13b - Cost of Revenue TTM 5.54b) / Revenue TTM)
Gross Margin QoQ = 41.22% (prev 37.79%)
Tobins Q-Ratio = 1.72 (Enterprise Value 29.9b / Total Assets 17.3b)
Interest Expense / Debt = 0.72% (Interest Expense 23.0m / Debt 3.18b)
Taxrate = 20.74% (264.0m / 1.27b)
NOPAT = 1.03b (EBIT 1.30b * (1 - 20.74%))
Current Ratio = 1.61 (Total Current Assets 4.39b / Total Current Liabilities 2.72b)
Debt / Equity = 0.31 (Debt 3.18b / totalStockholderEquity, last quarter 10.4b)
Debt / EBITDA = 1.03 (Net Debt 1.91b / EBITDA 1.86b)
Debt / FCF = 1.99 (Net Debt 1.91b / FCF TTM 960.0m)
Total Stockholder Equity = 11.0b (last 4 quarters mean from totalStockholderEquity)
RoA = 5.85% (Net Income 1.01b / Total Assets 17.3b)
RoE = 9.17% (Net Income TTM 1.01b / Total Stockholder Equity 11.0b)
RoCE = 9.66% (EBIT 1.30b / Capital Employed (Equity 11.0b + L.T.Debt 2.40b))
RoIC = 6.93% (NOPAT 1.03b / Invested Capital 14.8b)
WACC = 7.72% (E(27.9b)/V(31.1b) * Re(8.53%) + D(3.18b)/V(31.1b) * Rd(0.72%) * (1-Tc(0.21)))
Discount Rate = 8.53% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -46.06 | Cagr: -1.19%
[DCF] Terminal Value 76.55% ; FCFF base≈928.4m ; Y1≈1.00b ; Y5≈1.22b
[DCF] Fair Price = 72.19 (EV 18.8b - Net Debt 1.91b = Equity 16.9b / Shares 233.5m; r=8.35% [WACC [floored]]; 5y FCF grow 8.97% → 2.50% )
EPS Correlation: 99.75 | EPS CAGR: 16.16% | SUE: 2.49 | # QB: 1
Revenue Correlation: 89.63 | Revenue CAGR: 9.52% | SUE: -0.10 | # QB: 0
EPS current Quarter (2026-09-30): EPS=1.45 | Chg30d=-0.21% | Revisions=+22% | Analysts=20
EPS current Year (2026-12-31): EPS=5.66 | Chg30d=+2.19% | Revisions=+44% | GrowthEPS=+11.4% | GrowthRev=+1.8%
EPS next Year (2027-12-31): EPS=6.19 | Chg30d=+1.52% | Revisions=+18% | GrowthEPS=+9.4% | GrowthRev=+3.9%
[Analyst] Revisions Ratio: +35% (up=14, down=6)